MEDIUM confidence: 100% data completeness, but the composite (52) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Net insider -$404.9M over 180 days (0 open-market buys, 47 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Avg target $330 (last qtr, 31 analysts) → $332 (last mo, 26) (+0.5%).
Buy-rated share 93% → 95% over ~3 months (+3pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $1.82 | $5.75 | +215.9% |
| Apr 2026 | $1.63 | $2.78 | +70.6% |
| Feb 2026 | $1.97 | $1.95 | -1.0% |
| Oct 2025 | $1.57 | $1.95 | +24.2% |
| Jul 2025 | $1.31 | $1.68 | +28.2% |
| May 2025 | $1.37 | $1.59 | +16.1% |
| Feb 2025 | $1.49 | $1.86 | +24.8% |
| Oct 2024 | $1.14 | $1.43 | +25.4% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $469.8B— | $514.0B+9.4% | $574.8B+11.8% | $638.0B+11.0% | $716.9B+12.4% |
| EPS (dil.) | $3.24— | $-0.27-108.3% | $2.90n/m | $5.53+90.7% | $7.17+29.7% |
| Free Cash Flow | -$14.7B— | -$16.9Bn/m | $32.2Bn/m | $32.9B+2.1% | $7.7B-76.6% |
| Gross Margin | 42.0% | 43.8%+1.8pp | 47.0%+3.2pp | 48.9%+1.9pp | 50.3%+1.4pp |
| Operating Margin | 5.3% | 2.4%-2.9pp | 6.4%+4.0pp | 10.8%+4.3pp | 11.2%+0.4pp |
| Net Margin | 7.1% | -0.5%-7.6pp | 5.3%+5.8pp | 9.3%+4.0pp | 10.8%+1.5pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 13.4%/yr (revenue basis).
Base free cash flow $24.3B (avg FY2023–FY2025; latest year $7.7B) · equity value $2.89T · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 52 for AMZN indicates a neutral outlook, with the stock's strengths and weaknesses balancing out. AMZN scores high on momentum, driven by its 21.4% return over the past year, and exhibits strong growth, with 28.8% EPS growth. However, its value score is dragged down by a P/E of 21.3 and a P/B of 5.2, indicating the stock trades at a premium, while its risk score is negatively impacted by a beta of 1.5 and high 60-day volatility. The long-term and short-term scores are relatively aligned, with only a 3-point difference.